Authorized purpose: Adjunctive opportunistic coronary-calcium estimation during routine chest CT review, providing informational segmentation and Agatston estimates for physician assessment rather than a stand-alone diagnosis.
Clinical role
Adjunctive informational support for radiologist review in the standard workflow; the original patient report and CT remain available and physician review is required.
Images and patients
CT/CTA · Heart/Cardiovascular
Key limitation
Keep in mind: The cleared input is routine non-gated, non-contrast chest CT in patients aged 30 years and above. Results are informational and not intended for stand-alone clinical decision-making; the reviewed FDA validation used paired non-gated chest CT and gated coronary CT studies and should not be generalized beyond the described population and workflow.
Clinical detailsPurpose, workflow fit, evidence, and safety record
Workflow navigation pilot
Workflow role has not yet been reviewed for this navigation pilot.
A tag identifies a documented role; it does not establish compatibility or local acceptance. Methods and sources
What does this software do?Authorized purpose: Adjunctive opportunistic coronary-calcium estimation during routine chest CT review, providing informational segmentation and Agatston estimates for physician assessment rather than a stand-alone diagnosis.
Which images or clinical context are in scope?Modality: CT/CTA Anatomy or clinical context: Heart/Cardiovascular Input: Adult non-gated, non-contrast chest CT scans in DICOM format, transferred from an imaging database such as PACS or a DICOM router; the labeled age is 30 years and above.
Who uses it?Intended users: Qualified medical professionals, including radiologists and interpreting physicians.
What does the software produce?Output: An informational visual representation of estimated coronary-artery-calcium segmentation plus exact and four-category quantitative estimates of coronary calcium burden in Agatston units, viewable in the patient report and diagnostic image viewer.
What is its most important limitation?Key limitation: The cleared input is routine non-gated, non-contrast chest CT in patients aged 30 years and above. Results are informational and not intended for stand-alone clinical decision-making; the reviewed FDA validation used paired non-gated chest CT and gated coronary CT studies and should not be generalized beyond the described population and workflow.
Clinical takeaway. Clinical role: Adjunctive opportunistic coronary-calcium estimation during routine chest CT review, providing informational segmentation and Agatston estimates for physician assessment rather than a stand-alone diagnosis.
Evidence takeaway. Evidence from the reviewed source record: FDA validation used 762 paired studies from nine geographically diverse sites. Overall category alignment was 79.7%, and category-level positive predictive value ranged from 68.1% to 90.1%; the submission acceptance criteria were at least 73% alignment and at least 65% PPV for each category.
Evidence context
Evidence context not reviewed for this FDA record.
Public-label constraints
Label constraints have not been reviewed for this exact FDA record. Unknown is not all ages or evidence of unsuitability.
Public-label constraints, not patient-level eligibility or a medical recommendation. Training and evaluation populations are separate. Read the original labeling and confirm the exact release and protocol.
Purpose
Adjunctive opportunistic coronary-calcium estimation during routine chest CT review, providing informational segmentation and Agatston estimates for physician assessment rather than a stand-alone diagnosis.
Adjunctive informational support for radiologist review in the standard workflow; the original patient report and CT remain available and physician review is required.
Adult non-gated, non-contrast chest CT scans in DICOM format, transferred from an imaging database such as PACS or a DICOM router; the labeled age is 30 years and above.
An informational visual representation of estimated coronary-artery-calcium segmentation plus exact and four-category quantitative estimates of coronary calcium burden in Agatston units, viewable in the patient report and diagnostic image viewer.
The cleared input is routine non-gated, non-contrast chest CT in patients aged 30 years and above. Results are informational and not intended for stand-alone clinical decision-making; the reviewed FDA validation used paired non-gated chest CT and gated coronary CT studies and should not be generalized beyond the described population and workflow.
FDA validation used 762 paired studies from nine geographically diverse sites. Overall category alignment was 79.7%, and category-level positive predictive value ranged from 68.1% to 90.1%; the submission acceptance criteria were at least 73% alignment and at least 65% PPV for each category.
Metrics are shown only when they are tied to a source, endpoint, population, and tested product version. Candidate literature without exact product and version linkage is not shown as product evidence.
Evidence summary
FDA validation used 762 paired studies from nine geographically diverse sites. Overall category alignment was 79.7%, and category-level positive predictive value ranged from 68.1% to 90.1%; the submission acceptance criteria were at least 73% alignment and at least 65% PPV for each category.
DesignRetrospective paired-study validation comparing routine non-gated, non-contrast chest CT estimates with paired gated coronary CT reference categories and Agatston measurements.
Population762 paired CT studies from nine geographically diverse sites, with the calcium categories represented in the validation set.
Scopeexact submission
Tested versioniCAC Device configuration submitted in K230223
Samplen=762
Sites9
IndependenceSponsor or vendor study
K230223
The lower and upper PPV values are endpoints of the reported category span, not a single across-case range metric or a full-paper clinical-outcomes study.
Service-level context: CMS Transmittal 13702 (March 2026) establishes HCPCS G0680 under the hospital outpatient payment system, effective 2026-04-01, for software analysis of coronary artery calcium and/or aortic valve calcification from chest CT. Bunkerhill Health's 2026-04-15 release says CMS created a national billing code and payment for this analysis. CMS names no product, and the release does not name iCAC or state a code number. This is context for the service, not a determination that this product or release is covered or paid. No payment amount, status indicator or APC was read.
IT implementationDeployment, interfaces, data handling, and support
System and version relationships
Match the AI release, system build, configuration and region. Source documentation does not establish acceptance of an installed system.
No specific system/version pairing has completed review for this FDA record. A broad DICOM or product-family statement does not establish a named viewer build's support.
Public source context, not tested interoperability. Each hop needs its own release/configuration evidence. Missing or unavailable routes are not documented incompatibility. All local tests are planned, not passed; no installed-system acceptance is recorded.
Acquisition/source → routing → AI processing → returned objects → viewer/worklist/report → support owner
No specific route context has been source-reviewed for this record. Obtain both endpoint builds and documents; this is not a finding of incompatibility.
Acquisition/source
Source context, not route validation: Adult non-gated, non-contrast chest CT scans in DICOM format, transferred from an imaging database such as PACS or a DICOM router; the labeled age is 30 years and above.
Scope: Exact FDA submission.
Confirm scanner/model, protocol, series completeness and both software builds.
Source context, not route validation: The standalone SaMD receives DICOM from PACS or a DICOM router and can present the estimated score or category in a patient report, the segmentation in a diagnostic viewer, and an optional DICOM Secondary Capture series.
Scope: Exact FDA submission.
Name gateways, destinations, transfer rules and failure visibility; a DICOM statement does not prove a route.
Unresolved route: Not established for the exact route.
Scope: Exact FDA submission. The FDA summary establishes a standalone SaMD and DICOM/PACS-router workflow but does not establish the current exact configuration's hosting model.
Confirm processing location, queue ownership, exclusions and exact AI build.
Field checked 2026-09-07 ·
Returned objects
Source context, not route validation: An informational visual representation of estimated coronary-artery-calcium segmentation plus exact and four-category quantitative estimates of coronary calcium burden in Agatston units, viewable in the patient report and diagnostic image viewer.
Scope: Exact FDA submission.
Confirm object classes, units, references and whether findings, overlays or measurements reach their intended destination.
Unresolved route: An informational visual representation of estimated coronary-artery-calcium segmentation plus exact and four-category quantitative estimates of coronary calcium burden in Agatston units, viewable in the patient report and diagnostic image viewer.
Scope: Exact FDA submission.
Confirm the named viewer/worklist/report build, display behavior and report transfer. Output support alone does not establish this endpoint. The displayed source describes output, not validated end-to-end delivery.
Unresolved route: Not established for the exact route.
Scope: Scope not established.
Name the local, platform and AI supplier support owners and escalation path.
Planned local route tests
No tests below have been performed or accepted.
Patient/study identity (planned). Use approved non-patient test data to verify identifiers, accession and result-to-study linkage at every hop.
Study completeness (planned). Test missing views/series, partial transfer, late arrivals, priors and unsupported acquisition inputs; confirm explicit refusal or fallback.
Ordering and duplicates (planned). Send out-of-order, repeated and corrected studies; verify worklist order, deduplication and no misleading stale results.
Report transfer (planned). Verify output object types, annotations, units, report content, destination and availability of original images.
Access (planned). Verify authorized roles, audit trail, denied access and support ownership at each destination.
Latency and failures (planned). Agree a workload and turnaround target; test queues, timeouts, missing results and fallback reading.
Updates and rollback (planned). Define version change control, revalidation triggers, stop-use criteria and a tested rollback route.
Local implementation checklist
Agree the evidence and acceptance owner with your team and suppliers. Checkmarks apply to this page only and are not acceptance receipts.
The standalone SaMD receives DICOM from PACS or a DICOM router and can present the estimated score or category in a patient report, the segmentation in a diagnostic viewer, and an optional DICOM Secondary Capture series.
Bunkerhill Health's website states SOC 2 Type II certification, HIPAA compliance and ISO/IEC 27001:2022 certification. Badges only: no scope, dates or controls are given. Vendor-wide.
Vendor-wide
Checked 2026-10-25
Vendor statement, not an attestation; exact-release scope is not established.
The cleared standalone SaMD receives routine non-gated, non-contrast chest CT through DICOM transfer from an imaging database such as PACS or a DICOM router and can return report, viewer and optional DICOM Secondary Capture outputs.
Bunkerhill states that its current Carebricks product uses the FDA-cleared iCAC algorithm to detect and quantify CAC on routine non-gated chest CT and describes follow-up prioritization and care coordination for health systems.
product family · checked 2026-09-07
This vendor announcement supports current family workflow context; it does not establish exact K230223 release performance, installation, price, security or support terms.
Sources & review detailsFDA identity, research record, source ledger, and history
Regulatory identity
FDA record and catalog context
The FDA listing establishes the regulatory identity. It does not by itself establish local workflow fit, pricing, security, or performance in your environment.
This audit distinguishes completed source review from fields that have not yet been researched.
Exact FDA record reviewedStatus
2026-09-07Last searched
24Fields reviewed
12Source classes checked
20Screened PubMed leads
10Screened trial leads
0Unreviewed FDA recall leads
Stored candidate metadata was screened. The broad iCAC query returned 20 PubMed and 10 trial identifiers without exact K230223 linkage established in metadata; no full paper or trial record was reviewed, and no candidate is promoted as product evidence. The current discovery snapshot contains 20 PubMed and 10 ClinicalTrials.gov candidate records; its dated, count-matched human screening remains current. Unlinked candidates remain quarantined. Native FDA recall identifiers produced 0 postmarket candidate records; 0 have been reviewed (0 published, 0 rejected) and 0 remain unreviewed.
Candidate leads were screened against the exact product and tested version. Unlinked records remain quarantined.
Source classes: fda ai list, fda decision summary, acr ai central product, vendor documentation, vendor announcement, stored candidate metadata, literature index, trial registry, payer policy, pubmed, clinical trials, openfda device recall
Field review details
Recorded state, verification date, notes and sources for fields without a publishable value. Conflicting records stay explicitly unsettled here; no plain settled value is shown for them.
Public pricing: Not verified - checked 2026-09-07 - Exact FDA submission
No public price or quote for the exact K230223 configuration was reviewed.
Pricing model: Not yet reviewed
Setup and integration fees: Not yet reviewed
Recurring fees: Not yet reviewed
Minimum commitment: Not yet reviewed
Contract duration: Not yet reviewed
Renewal terms: Not yet reviewed
Cancellation terms: Not yet reviewed
Support and service terms: Not yet reviewed
Trial or pilot terms: Not yet reviewed
Deployment: Not publicly available - checked 2026-09-07 - Exact FDA submission
The FDA summary establishes a standalone SaMD and DICOM/PACS-router workflow but does not establish the current exact configuration's hosting model.
Data hosting location: Not yet reviewed
Data retention: Not yet reviewed
Documented data use: Not yet reviewed
Hardware requirements: Not yet reviewed
Network requirements: Not yet reviewed
Identity and access: Not yet reviewed
Installation timeline: Not yet reviewed
Training: Not verified - checked 2026-10-27 - Exact FDA submission
Current training prerequisites, competency checks, and support commitments for the exact configuration require vendor confirmation.
Monitoring: Not verified - checked 2026-10-27 - Exact FDA submission
Current drift, quality, uptime, alert, escalation, and incident-response commitments for the exact configuration require vendor confirmation.
Authorized purpose: cvi42 Coronary Plaque supports qualified professionals with viewing, post-processing, and qualitative and quantitative evaluation of adult cardiac CT DICOM images to assess the presence and extent of coronary plaques and stenoses in CCTA for CAD or suspected CAD.
Authorized purpose: Careverse CoronaryDoc is a web-based tool for trained medical professionals to view and analyze CCTA CT data for coronary plaques and stenosis, with coronary measurements, visualization, automated plaque and stenosis outputs, and structured reporting for physician review.
Copy this public context and add the field, proposed wording and original source before sending. Nothing here is submitted automatically. Form-specific prefill has not been verified.
Permission to display a submission is not evidence verification. A submission enters editorial review; it does not approve a public change. Form availability, data entry, receipt, review and publication are separate steps. Data entry and receipt remain unverified.
Accepted repository change history
No entry has been added to this scoped change history for this record. This is not proof that the record never changed.